Product Code: SR112024A4134
The global surgical drainage devices market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.5% during 2024-2032.
Surgical drainage devices are used to remove the contents of different organs, secretion of body cavities, and blood, serum, lymph, and other tissue fluids that accumulate in wound beds after surgical procedures. These devices minimize pressure on the surgical site and adjacent organs, nerves, and blood vessels, thereby reducing pain and enhancing wound perfusion and healing. They find application in urinary catheters, nasogastric tubes, chest drainage, and infected cysts. Presently, various surgical drainage devices made using latex, silicone, polyethylene, and polyvinyl chloride (PVC) are available worldwide, depending on the patient's surgery and wound.
Surgical Drainage Devices Market Trends:
A significant increase in the number of surgical procedures relating to the chest, lymph node, breast, abdominal, and thyroid represents one of the key factors propelling the market growth. Surgical drainage devices facilitate the healing process by removing inflammatory mediators, bacteria, foreign material, and necrotic tissues. Moreover, the rising demand for plastic surgery due to the increasing willingness among individuals to undergo reconstructive and cosmetic surgeries is bolstering the market growth. Apart from this, surgical drainage devices monitor potential complications and relieve the pressure that can impair perfusion or cause pain, thereby decreasing morbidity. Consequently, the rising incidence of neurosurgery with a high risk of raised intracranial pressure and orthopedic procedures associated with blood loss is influencing the market growth. Furthermore, they are widely being adopted in veterinary practice for surgical or traumatic wound management. The rising adoption of companion animals, along with the flourishing poultry and agriculture industries, is also contributing to market growth. Additionally, the growing focus on improving the functionality and reducing complications associated with drainage devices in surgeries is anticipated to drive the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global surgical drainage devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and end use.
Breakup by Product:
Active
Passive
Breakup by Application:
Cardio-Thoracic Surgeries
Neurosurgery Procedures
Abdominal Surgery
Orthopedics
Others
Breakup by End Use:
Hospitals
Clinics
Ambulatory Surgical Centers
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Acelity L.P. Inc. (3M Company), B. Braun Melsungen AG, Becton Dickinson and Company, Cardinal Health Inc., Cook Group Incorporated, Johnson & Johnson, Medela AG, Medtronic plc, Smith & Nephew plc, Stryker Corporation and Teleflex Incorporated.
Key Questions Answered in This Report:
- How has the global surgical drainage devices market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global surgical drainage devices market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end use?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global surgical drainage devices market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Surgical Drainage Devices Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Active
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Passive
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Application
- 7.1 Cardio-Thoracic Surgeries
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Neurosurgery Procedures
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Abdominal Surgery
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Orthopedics
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by End Use
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Clinics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Ambulatory Surgical Centers
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Acelity L.P. Inc. (3M Company)
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 B. Braun Melsungen AG
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 SWOT Analysis
- 14.3.3 Becton Dickinson and Company
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 Cardinal Health Inc.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Cook Group Incorporated
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 Johnson & Johnson
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Medela AG
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Medtronic plc
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Smith & Nephew plc
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Stryker Corporation
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Teleflex Incorporated
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis